Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiya Inada

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2009
Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese populationTomoko Tsunoka, Taro Kishi, Masashi Ikeda, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 19, 2009
Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese populationTaro Kishi, Tsuyoshi Kitajima, Masashi Ikeda, et al.
Psychiatry and Clinical Neurosciences|July 2, 2009
Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependenceYuko Okahisa, Hiroshi Ujike, Tatsuya Kotaka, et al.
Psychiatry and Clinical Neurosciences|April 17, 2008
Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophreniaAyako Nunokawa, Yuichiro Watanabe, Hideaki Kitamura, et al.
Neuropsychobiology|March 16, 2007
Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patientsShinichi Saito, Nagahide Takahashi, Ryoko Ishihara, et al.
Psychiatric Genetics|May 8, 2009
Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Neuropsychopharmacology Reports|December 10, 2021
Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case reportRyosuke Jozuka, Hiroki Kimura, Takashi Uematsu, et al.
International Clinical Psychopharmacology|February 28, 2026
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patternsRintaro Sogawa, Junji Uno, Akira Yoshimi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 21, 2011
Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese populationTaro Kishi, Tomo Okochi, Tsuyoshi Kitajima, et al.
Human Psychopharmacology|June 30, 2012
Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysisTaro Kishi, Yasuhisa Fukuo, Tomo Okochi, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 24, 2009
Association analysis of group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese populationTomoko Tsunoka, Taro Kishi, Masashi Ikeda, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 19, 2009
Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese populationTaro Kishi, Tsuyoshi Kitajima, Masashi Ikeda, et al.
Psychiatry and Clinical Neurosciences|July 2, 2009
Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependenceYuko Okahisa, Hiroshi Ujike, Tatsuya Kotaka, et al.
Psychiatry and Clinical Neurosciences|April 17, 2008
Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophreniaAyako Nunokawa, Yuichiro Watanabe, Hideaki Kitamura, et al.
Neuropsychobiology|March 16, 2007
Association study between vesicle-associated membrane protein 2 gene polymorphisms and fluvoxamine response in Japanese major depressive patientsShinichi Saito, Nagahide Takahashi, Ryoko Ishihara, et al.
Psychiatric Genetics|May 8, 2009
Association analysis of functional polymorphism in estrogen receptor alpha gene with schizophrenia and mood disorders in the Japanese populationTaro Kishi, Masashi Ikeda, Tsuyoshi Kitajima, et al.
Neuropsychopharmacology Reports|December 10, 2021
Severe and long-lasting neuropsychiatric symptoms after mild respiratory symptoms caused by COVID-19: A case reportRyosuke Jozuka, Hiroki Kimura, Takashi Uematsu, et al.
International Clinical Psychopharmacology|February 28, 2026
Antipsychotic polypharmacy in Japanese outpatients with schizophrenia: prevalence and sex- and age-related patternsRintaro Sogawa, Junji Uno, Akira Yoshimi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 21, 2011
Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese populationTaro Kishi, Tomo Okochi, Tsuyoshi Kitajima, et al.
Human Psychopharmacology|June 30, 2012
Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysisTaro Kishi, Yasuhisa Fukuo, Tomo Okochi, et al.
Pageof 25